Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic01:26

Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic

5.7K
Healthcare-associated infections (HAIs) occur in a healthcare facility while a person receives care for another ailment. This category also includes work-related infections among healthcare staff.
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
5.7K
Urinary Tract Infection IV: Nursing Management01:17

Urinary Tract Infection IV: Nursing Management

683
In managing urinary tract infections (UTIs) in nursing, a comprehensive assessment is essential. Begin by gathering subjective data, such as the patient’s complaints of dysuria (painful urination), urinary frequency, urgency, suprapubic pain, and any lower abdominal discomfort. This information can be complemented by questions regarding previous UTIs, sexual activity, and personal hygiene practices, which can provide insight into risk factors. Objective assessment should focus on signs...
683
Urinary Tract Infection II: Pathophysiology01:25

Urinary Tract Infection II: Pathophysiology

1.5K
The pathophysiology of urinary tract infections (UTIs) encompasses several progressive stages, beginning with bacterial colonization and culminating in potential systemic complications if untreated. UTIs are primarily initiated by bacteria, such as Escherichia coli, which often originate from the gastrointestinal tract and migrate to the urinary system through the periurethral area. This migration can occur via several routes, including improper hygiene practices, sexual activity, or...
1.5K
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

14.1K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
14.1K
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

1.4K
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
1.4K
Urinary Tract Infection I: Introduction01:26

Urinary Tract Infection I: Introduction

1.3K
Urinary tract infections (UTIs) impact various parts of the urinary system, including the kidneys, ureters, bladder, and urethra. These infections are generally bacterial, with Escherichia coli being the most common causative agent, often originating from the gastrointestinal tract. However, other bacteria, such as Staphylococcus saprophyticus, Klebsiella pneumoniae, and Proteus mirabilis, are also known to cause UTIs. The type, location, and underlying complexity of the UTI guide both...
1.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Genome-wide association study of paediatric bacteraemia and sepsis.

EBioMedicine·2026
Same author

Early detection and successful containment of Staphylococcus haemolyticus ST29 in a Swiss neonatal unit.

The Journal of hospital infection·2026
Same author

Early Oral Melatonin Supplementation Supports White Matter Maturation in Preterm Infants: Neuroprotective Insights of an Antioxidant Molecule.

Journal of pineal research·2026
Same author

Affinity-matured B cell responses neutralizing type-I interferons underlie severe viral infections.

Cell·2026
Same author

Did Nirsevimab Shift Pediatric Hospitalizations Due to Lower Respiratory Tract Infections? A Nationwide Italian Study (2024-2025).

Viruses·2026
Same author

Antibiotic Prophylaxis and Treatment of Neonatal Group B Streptococcus Disease in the Era of Antimicrobial Resistance.

Antibiotics (Basel, Switzerland)·2026

Related Experiment Video

Updated: May 1, 2026

Establishment of a Rat Model for Intrauterine Adhesions via Dual Injury: Curettage and Infection
11:44

Establishment of a Rat Model for Intrauterine Adhesions via Dual Injury: Curettage and Infection

Published on: October 3, 2025

1.9K

IUGR and infections.

Stefania Longo1, Alessandro Borghesi1, Chryssoula Tzialla1

  • 1Neonatal Intensive Care Unit, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.

Early Human Development
|April 9, 2014
PubMed
Summary
This summary is machine-generated.

Intra-uterine growth retardation (IUGR) and small for gestational age (SGA) infants face higher infection risks due to underdeveloped immune systems. Current immune therapies show limited effectiveness, necessitating further research for better infant outcomes.

Keywords:
IUGRInfectionIntrauterine growth retardationNewborn infantSGASepsis

More Related Videos

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
04:18

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice

Published on: October 10, 2025

735
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

5.5K

Related Experiment Videos

Last Updated: May 1, 2026

Establishment of a Rat Model for Intrauterine Adhesions via Dual Injury: Curettage and Infection
11:44

Establishment of a Rat Model for Intrauterine Adhesions via Dual Injury: Curettage and Infection

Published on: October 3, 2025

1.9K
Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
04:18

Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice

Published on: October 10, 2025

735
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis
08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

5.5K

Area of Science:

  • Perinatology
  • Immunology
  • Neonatology

Background:

  • Intra-uterine growth retardation (IUGR) signifies impaired fetal growth, with infants classified as small for gestational age (SGA) if birth weight is below the 10th percentile.
  • Congenital infections (e.g., CMV, rubella) are linked to 5-15% of IUGR cases.
  • SGA preterm infants exhibit increased susceptibility to post-natal and nosocomial infections compared to SGA infants.

Purpose of the Study:

  • To investigate the increased risk of post-natal infections in SGA preterm infants.
  • To explore the role of immune system development in IUGR-associated infections.
  • To evaluate the efficacy of current immune therapies in preventing sepsis in SGA infants.

Main Methods:

  • Review of existing literature on IUGR, SGA, congenital infections, and immune system development.
  • Analysis of studies examining immune parameters in SGA infants, including thymus size and leukocyte counts.
  • Assessment of clinical trial data for immune therapies like intravenous immunoglobulins and GM-CSF.

Main Results:

  • SGA preterm infants demonstrate a higher incidence of post-natal infections.
  • Retarded immune system development, including a small thymus and reduced leukocyte counts, is observed in SGA infants.
  • Prophylactic immune therapies have not effectively reduced sepsis incidence in this population.

Conclusions:

  • SGA preterm infants are at significant risk for post-natal infections due to immune system deficits.
  • Further research is crucial to develop effective strategies for preventing and treating infections in SGA infants.
  • The current understanding suggests a need for novel immune-modulating approaches for IUGR and SGA populations.